Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kansas Business Today.
Press releases published on April 26, 2025
No KYC. 100x Leverage. $50 Welcome Bonus. Crypto Futures Trading Made Easy on BexBack.
GlobeNewswire
·
April 26, 2025
SINGAPORE, April 26, 2025 (GLOBE NEWSWIRE) -- With Bitcoin's price fluctuating below $100,000, many analysts predict a prolonged period of high volatility in the crypto market. Holding spot positions may struggle to generate short-term profits in such …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Everus
GlobeNewswire
·
April 26, 2025
Faruqi …
The Asset with No Lobby: Jim Rickards Reveals the Most Valuable Untouched Resource in U.S. History
GlobeNewswire
·
April 26, 2025
WASHINGTON, April 26, 2025 (GLOBE NEWSWIRE) -- In a city shaped by special interests and trillion-dollar industries, one asset had no backers. No sponsors. No lobbyists in the room. And yet, according to former CIA advisor Jim Rickards, it may be the most …
Studies Show Breakthroughs in Male Contraception, Including First Male Contraceptive Hydrogel
GlobeNewswire
·
April 26, 2025
LAS VEGAS, April 26, 2025 (GLOBE NEWSWIRE) -- Groundbreaking research presented at the American Urological Association (AUA) Annual Meeting in Las Vegas is ushering in a new era for men’s reproductive health. Among this year’s highlights are the initial …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical
GlobeNewswire
·
April 26, 2025
Faruqi …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BigBear.ai
GlobeNewswire
·
April 26, 2025
Faruqi …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AppLovin
GlobeNewswire
·
April 26, 2025
Faruqi …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
GlobeNewswire
·
April 26, 2025
Faruqi …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Perpetua Resources Corp.
GlobeNewswire
·
April 26, 2025
Faruqi …
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
GlobeNewswire
·
April 26, 2025
Faruqi …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bakkt Holdings
GlobeNewswire
·
April 26, 2025
Faruqi …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ultra Clean
GlobeNewswire
·
April 26, 2025
Faruqi …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skyworks
GlobeNewswire
·
April 26, 2025
Faruqi …
These 5 AI trends Will Shape 2025, Says New Report
GlobeNewswire
·
April 26, 2025
SAN JUAN, Puerto Rico, April 26, 2025 (GLOBE NEWSWIRE) -- A recent analysis from GreenBot breaks down the top five AI trends that are already transforming how we interact with technology in 2025. As artificial intelligence continues to blend into the tools …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium
GlobeNewswire
·
April 26, 2025
Faruqi …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fluence Energy
GlobeNewswire
·
April 26, 2025
Faruqi …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Solaris Energy
GlobeNewswire
·
April 26, 2025
Faruqi …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of enCore
GlobeNewswire
·
April 26, 2025
Faruqi …
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron
GlobeNewswire
·
April 26, 2025
Faruqi …
Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
GlobeNewswire
·
April 26, 2025
TARA-002 demonstrates 100% complete response rate at any time and 67% 12-month landmark complete response rate in BCG-Unresponsive patients TARA-002 demonstrates 76% complete response rate at any time and 43% 12-month landmark complete response rate in BCG …